Benefits of an Insulin Dosage Calculation Device for Adolescents with Type 1 Diabetes Mellitus

• DOI: 10.1515/jpem.2004.17.12.1641
• Publication Date: 2011-04-15T11:12:30Z
• Authors: N.S. Glaser; S.B. Iden; D. Green-Burgeson; C. Bennett; K. Hood-Johnson; D.M. Styne; B. Goodlin-Jones
• Keywords: Metabolic control analysis; Regimen

Multiple daily injection insulin regimens (MDI) and continuous subcutaneous infusion (CSII) allow adolescents with type 1 diabetes mellitus (DM) meal flexibility, may improve metabolic control. The dosage calculations, however, involve ratios of to carbohydrate corrections for high blood glucose values, are labor-intensive prone error. We evaluated the impact an calculation device (IDC) on control, treatment satisfaction, regimen adherence quality life in using MDI or CSII.We conducted a randomized control trial IDC 83 CSII. At enrollment, patients received training either conventional methods, performed sample calculations. 6 months 12 months, we recorded HbA1c frequency hypoglycemia, completed questionnaires assessing life. After group were also given IDC.We observed higher errors calculations (53-67% incorrect calculations) than (25-32% incorrect). there was trend toward improved overall (9.3 vs 8.9, p = 0.07) significant improvement subset (42%) who used consistently (9.7 8.8, 0.03). There no change during this interval (9.0 0.90). During 6-12, when both groups combined, increase inconsistently not at all (8.9 9.4, 0.005), but those (9.1 0.57). Treatment throughout study groups.Errors by occur frequently. Consistent use help